Nov 5 (Reuters) - Vaccine maker Moderna's ( MRNA ) chief

executive officer Stephane Bancel will vacate his role as the

company's chief commercial officer, Bloomberg News reported on

Tuesday citing one person familiar with the matter.

The company's president Stephen Hoge will take charge of

sales as well as medical and research affairs, according to the

report.

Bancel will remain in his role as Moderna's ( MRNA ) CEO, the report

added. Moderna ( MRNA ) did not immediately respond to a Reuters request

for comment.

Moderna ( MRNA ) had announced in December Bancel would head sales

and marketing, and work directly with the company's commercial

team, after then commercial officer Arpa Garay had decided to

leave.